Alector Inc
Change company Symbol lookup
Select an option...
ALEC Alector Inc
BABA Alibaba Group Holding Ltd
JEQ abrdn Japan Equity Fund, Inc.
BAC Bank of America Corp
RVLWF Revitalist Lifestyle and Wellness Ltd
$NQUS45101010LMEURN Nasdaq US Brewers Large Mid Cap Net
$R25IG Russell 2500 Growth Index
TTC Toro Co
MPVDF Mountain Province Diamonds Inc
XFAPX abrdn Asia-Pacific Income Fund Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a therapeutic approach for the treatment of neurodegeneration. The Company is engaged in developing therapies designed to counteract these pathologies by restoring healthy immune function to the brain. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration and immunology to identify immune system. The Company has advanced four product candidates, AL001, AL002, AL003, and AL101, into clinical development. Its first product candidate, AL001, is a humanized recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of frontotemporal dementia carrying a progranulin (FTD-GRN) patients. Its AL002 targets triggering receptor expressed on myeloid cells 2 (TREM2) to increase the functionality of TREM2 signaling and enhance microglia cell activation.

Closing Price
$9.49
Day's Change
-0.07 (-0.73%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.74
Day's Low
9.28
Volume
(Average)
Volume:
628,550

10-day average volume:
597,509
628,550

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Core Scientific, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 13, 2023 - (NASDAQ: CORZ)

5:45 am ET December 7, 2022 (PR Newswire) Print

The Gross Law Firm issues the following notice to shareholders of Core Scientific, Inc..

Shareholders who purchased shares of CORZ during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/core-scientific-inc-loss-submission-form/?id=34311&from=4

CLASS PERIOD: January 3, 2022 to October 26, 2022

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) due in part to the expiration of a favorable pricing agreement, the Company was experiencing increasing power costs; (2) the Company's largest customer, Gryphon Digital Mining, lacked the financial resources to purchase the necessary miner rigs for Core Scientific to host; (3) the Company was not providing hosting services to Celsius Network LLC ("Celsius") as required by their contract; (4) the Company had implemented an improper surcharge to pass through power costs to Celsius; (5) as a result of the foregoing alleged breaches of contract, the Company was reasonably likely to incur liability to defend itself against Celsius; (6) as a result of the foregoing, the Company's profitability would be adversely impacted; (7) as a result, there was likely substantial doubt as to the Company's ability to continue as a going concern; and (8) as a result of the foregoing, defendant's positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE: January 13, 2023 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/core-scientific-inc-loss-submission-form/?id=34311&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of CORZ during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is January 13, 2023. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: dg@securitiesclasslaw.comPhone: (646) 453-8903

https://c212.net/c/img/favicon.png?sn=NY58375&sd=2022-12-07

View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-core-scientific-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-january-13-2023--nasdaq-corz-301696573.html

SOURCE The Gross Law Firm

https://rt.newswire.ca/rt.gif?NewsItemId=NY58375&Transmission_Id=202212070545PR_NEWS_USPR_____NY58375&DateId=20221207

comtex tracking

COMTEX_420362692/1005/2022-12-07T05:45:08

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.